Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • August News and Product Briefs

    Aug 29, 2014, 08:45 AM by Michael Croft
    Bio-IT World | News and product releases from around the industry, including a trial to support broad genotyping of tumors, and new annotation tools from Appistry.
    Full story
  • Rafer SL invests in Spanish NGS leader Era7 Bioinformatics to accelerate Era7's International expansion plan

    Aug 29, 2014, 00:00 AM by Michael Croft
    GRANADA AND ZARAGOZA, SPAIN - Aug 29, 2014 - Era7 Bioinformatics and Comercial Rafer announced today that Rafer has made a strategic investment in Era7 Bioinformatics to accelerate the International expansion of Era7 Bioinformatics, the bacterial genomics company
    Full story
  • Berg and the Pursuit of the Body's Hidden Drugs

    Aug 28, 2014, 10:15 AM by Michael Croft
    Bio-IT World | Berg, a Cambridge-based pharma company, believes human cells may be harboring compounds that could be used to treat diabetes, cancer, and neurological diseases. To find them, they're handing tissue samples over to their in-house data mining platform, Interrogative Biology.
    Full story
  • DNA Barcoding to Combat Mass Food Fraud

    Aug 26, 2014, 09:10 AM by Michael Croft
    Chemical & Engineering News | Armed with new technologies to identify food products on a molecular level, regulators are combating the multi-billion dollar international practice of food fraud.
    Full story
  • Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings

    Aug 26, 2014, 00:00 AM by Michael Croft
    BASEL, SWITZERLAND - Aug 26, 2014 -  Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the Genedata® Screener Global User Group Meetings will be held in Asia, Europe, and North America during September 2014
    Full story
  • Updates from the Genome in a Bottle Consortium

    Aug 25, 2014, 10:25 AM by Michael Croft
    Bio-IT World | At the Next Generation Dx Summit in Washington, DC, Justin Zook of the National Institute of Standards and Technology discussed the pace of progress at the Genome in a Bottle Consortium, including new reference materials and the project's role in FDA evaluation of next-generation sequencing technologies.
    Full story
  • Research and Analytics Firm Evalueserve Acquires Beyond Data

    Aug 25, 2014, 00:00 AM by Michael Croft
    RHEINBACH, GERMANY - Aug 25, 2014 - Global research and analytics firm Evalueserve announced today the acquisition of German business intelligence provider Beyond Data GmbH
    Full story
  • Illumina to Support 'Companion Therapeutics' in Oncology

    Aug 21, 2014, 10:05 AM by Michael Croft
    Bio-IT World News Brief | Illumina today announced collaborations with AstraZeneca, Sanofi, and Janssen Biotech, to participate in patient stratification for the development of new cancer drugs by offering a multi-gene panel that covers key cancer mutations.
    Full story
  • Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S.

    Aug 21, 2014, 00:00 AM by Michael Croft
    ROCKVILLE, MD - Aug 21, 2014 -  Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U
    Full story
  • MolecularHealth Provides Unprecedented Reimbursement Support with RxAssistance

    Aug 21, 2014, 00:00 AM by Michael Croft
    THE WOODLANDS, TX, UNITED STATES - Aug 21, 2014 - MolecularHealth announced today an important new component of its TreatmentMAP™ offering in the United States, called MolecularHealth™ RxAssistance
    Full story
  • Seven Bridges Introduces Open Source Cancer Genomics Workflow

    Aug 20, 2014, 06:20 AM by Michael Croft
    Bio-IT World | After presenting an open source pipeline for analyzing cancer genomes at Cold Spring Harbor this May, Seven Bridges is seeking hospital and lab partners to test the system in a clinical setting.
    Full story
  • GeneDx Seeks Invalidation of Myriad's BRCA Patents

    Aug 20, 2014, 06:05 AM by Michael Croft
    Bio-IT World News Brief | GeneDx, a commercial genetic diagnostics lab located in Gaithersburg, Maryland, this week filed eleven petitions to invalidate patent claims held by Myriad Genetics, adding another new thread to the increasingly complicated web of litigation surrounding Myriad.
    Full story
  • Vortex to accelerate anti-infective research at the Institute for Molecular Bioscience at the University of Queensland, Australia

    Aug 20, 2014, 00:00 AM by Michael Croft
    BISHOP'S STORTFORD, UK - Aug 20, 2014 - ~~Dotmatics, a leading provider of scientific informatics solutions and services, announced today that Prof
    Full story
  • New Life Sciences Research Reveals Early Stage Treatments to Help Scientists in the Fight against Ebola

    Aug 19, 2014, 00:00 AM by Michael Croft
    PHILADELPHIA, PA - Aug 19, 2014 - The Intellectual Property and Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, released a comprehensive disease profile on Ebola Virus Disease that includes a detailed analysis of two new treatments in the pipeline and two experimental candidates approaching development
    Full story
  • A Sensitive Tool for Detecting Indels

    Aug 18, 2014, 13:05 PM by Michael Croft
    Bio-IT World News Brief | A team from Cold Spring Harbor Laboratory has released an open source algorithm, called Scalpel, for finding insertions and deletions in next generation sequencing data sets, and published a paper in Nature Methods using this tool to identify mutations in children affected by autism.
    Full story
  • Could Pharma Companies Succeed in the Digital Health Market?

    Aug 18, 2014, 11:35 AM by Michael Croft
    Forbes | Jason Bloomberg speaks to pharma executives and industry observers who believe top drug companies could soon focus more of their efforts on creating electronic health platforms, collecting user data and to more precisely define disease risks and personalize prevention and treatment.
    Full story
  • Phase Holographic Imaging Announces Collaboration Agreement with Northeastern University

    Aug 18, 2014, 00:00 AM by Michael Croft
    LUND, SWEDEN - Aug 18, 2014 - Phase Holographic Imaging today announces a collaboration agreement with Northeastern University of Boston
    Full story
  • BC Platforms receives government funding for R&D

    Aug 18, 2014, 00:00 AM by Michael Croft
    ESPOO, FINLAND - Aug 18, 2014 - BC Platforms has been qualified to receive Tekes funding for its R&D program for its large-scale clinical and genomic R&D solutions
    Full story
  • New Alignment Method to Speed Up De Novo Assembly of Whole Genomes

    Aug 15, 2014, 12:45 PM by Michael Croft
    Bio-IT World News Brief | A paper posted this week to the preprint server bioRxiv describes MHAP, a new tool that can reportedly assemble whole genomes de novo from long-read sequencing data hundreds of times faster than previous workflows.
    Full story
  • FDA Plans to Introduce Web Portal for Tracking Device Submissions

    Aug 15, 2014, 09:50 AM by Michael Croft
    Regulatory Focus | The FDA's Center for Devices and Radiological Health (CDRH) is piloting a program that would let companies track the progress of medical devices and diagnostic tests submitted for premarket approval through the agency's review process.
    Full story
  • «
  • 391
  • 392
  • 393
  • 394
  • 395
  • 396
  • 397 (current)
  • 398
  • 399
  • 400
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy